tiprankstipranks
Analyst Profile
Followed by 11 other investors
.
Trung Huynh

Trung Huynh

Credit Suisse
Wall Street Analyst
Ranked #1,000 out of 8,045 Analysts on TipRanks (#1,703 out of 21,519 overall experts)

Success Rate

78%
54 out of 69 Profitable Transactions

Average Return

13.00%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
If you copied Trung Huynh's ratings since 2020 and opened each position for the duration of 1 Year:
78.26% of your transactions would have been profitable with an average return of 13.0%

Stock Rating Distribution

138Ratings
44.20% Buy
43.48% Hold
12.32% Sell
Distribution of Trung Huynh's ratings

Additional Information

Main Sector:General
Geo Coverage:
United KingdomUK Market
United StatesUS Market

Best Rating

Stock:
Merck KGaA
(0O14)
Rating Type:Buy
Dates:Sep 16, 2020 - Sep 16, 2021
Gain:61.00%
The most profitable rating made by Trung Huynh

Trung Huynh's Stock Coverage

Company Name
Date
Position
Action
Price Target
Success Rate
Avg Return
No. of Ratings
Genmab
Jun 25, 2020
Hold
Downgraded
$3.08
(-91.72% Downside)
100%
+41.80%
2
UCB SA
Jul 28, 2020
Hold
Reiterated
€83.00
(12.75% Upside)
0.00%
1
Novo Nordisk
Oct 12, 2020
Buy
Reiterated
$64.82
(-39.07% Downside)
100%
+31.95%
3
Orion Corporation
Jan 20, 2021
Sell
Reiterated
€35.00
(-24.32% Downside)
100%
+2.70%
1
AstraZeneca
Apr 08, 2021
Buy
Reiterated
100%
+47.10%
1
Sanofi
Apr 29, 2021
Buy
Reiterated
$98.48
(16.59% Upside)
92%
+7.62%
16
Merck KGaA
May 13, 2021
Buy
Reiterated
€165.00
(-10.19% Downside)
100%
+32.83%
12
GlaxoSmithKline
Jun 22, 2021
Sell
Reiterated
1,400.00p
(-0.54% Downside)
0%
-31.70%
13
Grifols SA
Aug 04, 2021
Buy
Reiterated
$27.70
(210.49% Upside)
0%
-38.55%
2
Grifols
Aug 04, 2021
Buy
Reiterated
€27.00
(96.29% Upside)
0%
-30.75%
6
List of latest recommendations made by Trung Huynh. Click to expand and see Trung Huynh's performance on a particular stock
Disclaimer: TipRanks collects ratings and price targets of analysts by scanning publicly available reports on financial websites and by receiving reports directly from the analysts or from our users. The information displayed and the Analyst Profile statistics might not be accurate, complete, or up to date. The analyst ratings provided are entirely at the sole responsibility of the of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings or opinions expressed on the site.
Are We Missing a Rating?
Send us the equity research you are getting and become a Power User
Learn More